JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoon, J H
Right arrow Articles by Kim, B K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, J H
Right arrow Articles by Kim, B K
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Genetics Home Reference
Journal of Clinical Pathology 2002;55:410-413
© 2002 Journal of Clinical Pathology


ORIGINAL ARTICLE

Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria

J H Yoon1, H I Cho1, S S Park1, Y H Chang1, B K Kim2

1 Department of Clinical Pathology, Seoul National University College of Medicine, Seoul, Korea 110–744; slice{at}hitel.net
2 Department of Internal Medicine, Seoul National University College of Medicine

Correspondence to:
Dr H I K Cho, Department of Clinical Pathology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110–744, Korea;
hanik{at}snuh.snu.ac.kr Aim: Paroxysmal nocturnal haemoglobinuria (PNH) is caused by deficient biosynthesis of the glycosylphosphatidylinositol (GPI) anchor in haemopoietic stem cells. Mutation of the phosphatidylinositol glycan class A (PIG-A) gene, an X linked gene that participates in the first step of GPI anchor biosynthesis, is responsible for PNH. The characteristics of somatic mutation of the PIG-A gene in Korean patients with PNH were studied.

Methods: Twenty four patients with PNH were selected. Ham tests and sucrose haemolysis tests were carried out on all patients. The expression of CD59 in erythrocytes and granulocytes was investigated in 14 and five patients, respectively, to confirm the diagnosis. Dideoxy fingerprinting (ddF) was used to screen mutations, and direct sequencing of DNA was performed to characterise the mutations.

Results: Gene mutation was detected in 12 of the 24 patients. The other 12 patients were negative in ddF screening. Ten new mutations and two known mutations were detected. The mutations consisted of five deletions, six substitutions, and one insertion. These mutations resulted in six premature terminations, three abnormal splicings, one missense mutation in exon 2, and two nonsense mutations. Two patients with venous thrombosis showed mutations in exon 3 only. Substitution mutations were seen in six patients and frameshift mutations in the other six.

Conclusions: There were 10 new mutations among the 12 mutations in the Korean patients with PNH and the characteristics of the mutations varied, with no significant hot spots in sites or types.


Keywords: paroxysmal nocturnal haemoglobinuria; mutation; phosphatidylinositol glycan class A (PIG-A) gene; glycosylphosphatidylinositol anchor; dideoxy fingerprinting

Abbreviations: ddF, dideoxy fingerprinting; GPI, glycosylphosphatidylinositol anchor; PCR, polymerase chain reaction; PIG-A, phosphatidylinositol glycan class A; PNH, paroxysmal nocturnal haemoglobinuria




This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
J. S Krauss
Laboratory Diagnosis of Paroxysmal Nocturnal Hemoglobinuria
Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 401 - 406.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.